Cargando…
Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics
The idiotype network is experimentally modified to provide protective immunity against various microbial pathogens. Both internal and non-internal image-idiotype antibodies can trigger specific immune responses to antigens. The current outbreak of Severe Acute Respiratory Syndrome 2 (SARS-2) has pro...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380862/ https://www.ncbi.nlm.nih.gov/pubmed/34458584 http://dx.doi.org/10.1186/s41231-021-00097-y |
_version_ | 1783741257398353920 |
---|---|
author | Naveed, Ahsan Naz, Deeba Rahman, Sajjad ur |
author_facet | Naveed, Ahsan Naz, Deeba Rahman, Sajjad ur |
author_sort | Naveed, Ahsan |
collection | PubMed |
description | The idiotype network is experimentally modified to provide protective immunity against various microbial pathogens. Both internal and non-internal image-idiotype antibodies can trigger specific immune responses to antigens. The current outbreak of Severe Acute Respiratory Syndrome 2 (SARS-2) has provided a great opportunity to take advantage of idiotype / anti-idiotype antibodies as a protective regimen when no approved vaccine is available on earth. The current review identifies successful applications of idiotype/ anti-idiotype antibodies in various viral diseases and highlights their importance in COVID-19 pandemics. In the absence of vaccines and targeted therapies, polyclonal idiotype/ anti-idiotype antibodies against the viral structure may be a potential approach to the prevention and treatment of COVID-19 patients. |
format | Online Article Text |
id | pubmed-8380862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-83808622021-08-23 Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics Naveed, Ahsan Naz, Deeba Rahman, Sajjad ur Transl Med Commun Review The idiotype network is experimentally modified to provide protective immunity against various microbial pathogens. Both internal and non-internal image-idiotype antibodies can trigger specific immune responses to antigens. The current outbreak of Severe Acute Respiratory Syndrome 2 (SARS-2) has provided a great opportunity to take advantage of idiotype / anti-idiotype antibodies as a protective regimen when no approved vaccine is available on earth. The current review identifies successful applications of idiotype/ anti-idiotype antibodies in various viral diseases and highlights their importance in COVID-19 pandemics. In the absence of vaccines and targeted therapies, polyclonal idiotype/ anti-idiotype antibodies against the viral structure may be a potential approach to the prevention and treatment of COVID-19 patients. BioMed Central 2021-08-23 2021 /pmc/articles/PMC8380862/ /pubmed/34458584 http://dx.doi.org/10.1186/s41231-021-00097-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Naveed, Ahsan Naz, Deeba Rahman, Sajjad ur Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics |
title | Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics |
title_full | Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics |
title_fullStr | Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics |
title_full_unstemmed | Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics |
title_short | Idiotype/anti-idiotype antibodies: as a glorious savior in COVID-19 pandemics |
title_sort | idiotype/anti-idiotype antibodies: as a glorious savior in covid-19 pandemics |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380862/ https://www.ncbi.nlm.nih.gov/pubmed/34458584 http://dx.doi.org/10.1186/s41231-021-00097-y |
work_keys_str_mv | AT naveedahsan idiotypeantiidiotypeantibodiesasaglorioussaviorincovid19pandemics AT nazdeeba idiotypeantiidiotypeantibodiesasaglorioussaviorincovid19pandemics AT rahmansajjadur idiotypeantiidiotypeantibodiesasaglorioussaviorincovid19pandemics |